Literature DB >> 21537594

Maxillary ameloblastic fibroma: a case report.

Daniela Otero Pereira da Costa1, Adriana Terezinha Neves Novellino Alves, Mônica Diuna Calasans-Maia, Ricardo Lopes da Cruz, Simone de Queiroz Chaves Lourenço.   

Abstract

Ameloblastic fibroma is a relatively rare benign odontogenic tumor in which both the epithelial and ectomesenchymal components are neoplastic. An 8-year-old Caucasian boy was referred to the dentist for evaluation of failed eruption of the maxillary left first molar. The panoramic radiograph showed a well-circumscribed unilocular radiolucency involving an unerupted maxillary left first permanent molar. The lesion was enucleated and the material was sent for histopathologic examination. Microscopically, it was composed by cords and islands of odontogenic epithelium in a myxoid cell-rich stroma that closely resemble the dental papilla with histopathological diagnosis of ameloblastic fibroma. After 24 months of follow-up no recurrence was observed and the maxillary left first molar erupted spontaneously through the buccal mucosa and was aligned with a fixed orthodontic appliance. This case emphasized the importance of careful differential diagnosis of intraosseous oral lesions and reported a rarity of the lesion and its atypical location.

Entities:  

Mesh:

Year:  2011        PMID: 21537594     DOI: 10.1590/s0103-64402011000200015

Source DB:  PubMed          Journal:  Braz Dent J        ISSN: 0103-6440


  2 in total

1.  Ameloblastic fibroma of the maxilla with bilateral presentation: report of a rare case with review of the literature.

Authors:  Kranti Kiran Reddy Ealla; Vijayabaskar Reddy Basavanapalli; Surekha Reddy Velidandla; Sangameshwar Manikya; Rajesh Ragulakollu; Prasanna M Danappanavar; Vijayasree Vennila
Journal:  Case Rep Pediatr       Date:  2015-01-05

2.  Recurrent ameloblastic fibroma: report of a rare case.

Authors:  Ravikumar S Kulkarni; Amitabh Sarkar; Sandeep Goyal
Journal:  Case Rep Dent       Date:  2013-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.